• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·003017.SZ
Share

Zhe Jiang Dayang Biotech Group Co., Ltd. Stocks

CN¥ 21.66Last Updated 14.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 277.07M

CN¥ 21.66
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Zhejiang Dayang Biology Technology Co.,Ltd. is a diversified enterprise specializing in the research, development, manufacturing, and global distribution of biological products, agricultural chemicals, and a broad spectrum of chemical compounds. Its extensive product portfolio includes a range of fundamental inorganic chemicals such as potassium carbonate (available in both general and food additive grades) and potassium bicarbonate (also offered as a food additive). They also supply ammonium chloride, catering to both agricultural and industrial needs. Beyond these, the company produces more specialized chemical derivatives, including 2-chloro-6-fluorobenzaldehyde, 2-chloro-6-fluorobenzyl chloride, and various anisole-based products. Furthermore, Zhejiang Dayang is a supplier of veterinary active pharmaceutical ingredients (APIs), exemplified by amprolium HCL, and manufactures veterinary drug premixes, such as enramycin premixes. Established in 1976, the company maintains its headquarters in Jiande, China.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 11:10

Oil prices soared to a one-month high following new attacks by the U.S. and Iran in the Strait of Hormuz

14.07.2026 10:44

Intraday volatility: SK Hynix shares rebounded after a 9% plunge

14.07.2026 10:38

Morning Highlights: Oil Prices Rise Amid Strikes on Iran; Nvidia Tightens Export Controls

14.07.2026 09:30

Sam Altman "took the scam to a whole new level": Musk comments on Apple's lawsuit against OpenAI

14.07.2026 08:30

Disney's decision to abandon streaming will boost its stock by 40% — Wells Fargo

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026